Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Generics
Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.   24 March 2020
Big Pharma
Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.   24 March 2020
Europe
UK engineering company Smiths Group is making the IP covering one of its ventilators available to other manufacturers, as part of an industry attempt to tackle the shortage of life-saving equipment.   23 March 2020
Americas
California-based Pacific Biosciences has accused a UK rival of exploiting the coronavirus pandemic in a patent infringement trial.   19 March 2020
Americas
Biogen and the University of Zurich have accused New York-based Creative Biolabs of unlawfully selling copies of Biogen’s aducanumab antibody.   19 March 2020
Americas
The US Court of Appeals for the Federal Circuit has ruled that two Illumina DNA detection patents are valid, in a reversal of a California district court.   19 March 2020
Americas
Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.   19 March 2020
Americas
German authorities have reacted angrily to media reports that US President Donald Trump offered $1 billion to CureVac, a Germany-based company seeking a COVID-19 vaccine, to move its operations to the US.   17 March 2020
Big Pharma
The US Court of Appeals for the Federal Circuit has rescued one Boehringer Ingelheim patent, covering a type 2 diabetes treatment, from invalidation but affirmed a New Jersey district court’s cancellation of two others.   17 March 2020
Big Pharma
The World Health Organization has launched a Solidarity Response Fund, offering companies, foundations and individuals the chance to donate to the WHO’s global response to the ongoing COVID-19 pandemic.   16 March 2020